• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Indonesia’s Healthcare Superapp Alodokter Raises $33m in Series C Funding

Share:

October 29, 2019

The startup will use the funds to expand its hospital network integration and to further develop its health insurance service.

Indonesia-based healthcare superapp Alodokter announced that it has raised a $33M Series C funding led by Sequis Life and with participation from Philips, Heritas Capital, Hera Capital, Dayli Partners and others. Existing investors Softbank Ventures Asia and Golden Gate Ventures also participated in the round. The startup was founded in 2014 by Suci Arumsari (Co-founder & Director Alodokter) & Nathanael Faibis (Co-founder & CEO Alodokter).

Alodokter will use the funds to expand its hospital network integration and to further develop its health insurance service. In 2018, the company launched a health insurance called “Alodokter Protection”. Policyholders can subscribe, pay and claim directly in the app. They can also access a suite of premium services, such as unlimited online consultations and premium access to hospitals.

According to its press release, Aoldokter currently has about 20 million monthly active users on its platform and they use the app to chat with doctors, book appointments, discover personalised content and manage their health insurance. It works with a trusted network of 20,000 doctors and 1,000 hospitals and clinics.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

THE LARGER TREND

Halodoc, a big player in the healthtech space in Indonesia, has raised close to a total of $100M after its latest funding round, MobiHealth News reported in late July. Halodoc operates a mobile platform for patients to access doctors any time of the day and pharmacy delivery across 50 cities, as well as home lab services, increasing accessibility to easy, affordable, and reliable healthcare services. On average, Halodoc serves around 7 million patients per month throughout Indonesia with 80% of patients residing outside the main cities of Jakarta and Surabaya.

Alodokter sees enormous opportunity in Indonesia’s largely untapped private health insurance market with a penetration of less than 2%, 10 times lower than its neighbour Malaysia – this explains its drive to develop its health insurance service in the country.

ON THE RECORD

“Indonesia’s medical system has been going through massive changes over the last 10 years and is keener to embrace digital innovation than more mature markets. Indonesia is becoming one of the first digitally native medical systems in the world. That’s been one of the key factors for the hyper growth we have been experiencing since our launch,” said CEO Nathanael Faibis in a statement.

Suci Arumsari, co-founder of Alodokter, said: “Finding the right medical information, the right doctor and the right financial solution can be overwhelming for families all over Indonesia. I am the typical user of Alodokter as a mother of two young kids, but limited medical knowledge. Alodokter changed my life when it comes to managing my family’s health. We want to be the guardian angel of all Indonesian families.”

Source: MobiHealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Top Tech Trends In 2019Top Tech Trends In 2019
  • Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection AlgorithmsEko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms
  • Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer PackagingAmcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging
  • Artificial Intelligence Could Increase Clinical Trial Success RatesArtificial Intelligence Could Increase Clinical Trial Success Rates
  • Amedisys Completes Acquisition of Asana HospiceAmedisys Completes Acquisition of Asana Hospice
  • Phoenix Rehabilitation & Health Services, Inc. Acquires CACC Physical TherapyPhoenix Rehabilitation & Health Services, Inc. Acquires CACC Physical Therapy
  • Zydus Launches Denosumab Biosimilar for CancerZydus Launches Denosumab Biosimilar for Cancer
  • Janssen Taps Komodo Health to Optimize Site Selection and Patient Recruitment for Clinical TrialsJanssen Taps Komodo Health to Optimize Site Selection and Patient Recruitment for Clinical Trials

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications